Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤上漲約0.1％。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
Rezolute
Rezolute
- The Trade: Rezolute, Inc. (NASDAQ:RZLT) Chief Medical Officer Brian Kenneth Roberts acquired a total of 7,000 shares an average price of $1.31. To acquire these shares, it cost around $9,142.
- What's Happening: Rezolute posted a narrower-than-expected quarterly loss.
- What Rezolute Does: Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies.
- 貿易：Rezolute, Inc.（納斯達克股票代碼：RZLT）首席醫療官布萊恩·肯尼思·羅伯茨 共收購了 7,000 股股份 平均價格爲1.31美元。收購這些股票的成本約爲9,142美元。
- 發生了什麼：Rezolute公佈的季度虧損低於預期。
- Rezolute做什麼：Rezolute Inc是一家生物製藥公司。該公司開發新型的緩釋注射療法。
Cosmos Health
宇宙健康
- The Trade: Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired a total of 60,000 shares at at an average price of $0.83. To acquire these shares, it cost around $49,806.
- What's Happening: Cosmos Health announced that it has successfully completed the acquisition of Cloudscreen, a cutting-edge Artificial Intelligence (AI) powered platform.
- What Cosmos Health Does: Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'.
- 交易：Cosmos Health Inc.（納斯達克股票代碼：COSM）首席執行官格里戈里奧斯·西奧卡斯 共收購了 60,000 股股票 平均價格爲0.83美元。收購這些股票的成本約爲49,806美元。
- 發生了什麼：Cosmos Health宣佈已成功完成對Cloudscreen的收購，Cloudscreen是一個尖端的人工智能（AI）驅動平台。
- Cosmos Health的所作所爲：Cosmos Health Inc通過自己的專有產品線 “Sky Premium Life” 和 “地中海” 涉足營養品領域。
Check This Out: NVIDIA, Keurig Dr Pepper And 3 Stocks To Watch Heading Into Thursday
看看這個： NVIDIA、Keurig Dr Pepper 和 3 只股票在週四值得關注
InMed Pharmaceuticals
InMed 製藥
- The Trade: InMed Pharmaceuticals Inc. (NASDAQ:INM) President and CEO Eric A Adams acquired a total of 41,600 shares at an average price of $0.36. The insider spent around $14,922 to buy those shares.
- What's Happening: InMed Pharmaceuticals, during October, said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.
- What InMed Pharmaceuticals Does: InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company.
- 交易：InMed 製藥公司（納斯達克股票代碼：INM）總裁兼首席執行官埃裏克·亞當斯 共收購了41,600股股票 平均價格爲0.36美元。知情人士花費了約14,922美元購買了這些股票。
- 發生了什麼：InMed Pharmaceuticals在10月份表示，根據積極的概念驗證研究數據，它選擇了一種主要的阿爾茨海默氏症候選藥物。
- InMed 製藥公司做什麼：InMed Pharmaceuticals Inc是一家總部位於加拿大的臨床階段生物製藥公司。
Charles & Colvard
查爾斯和科爾瓦德
- The Trade: Charles & Colvard, Ltd. (NASDAQ:CTHR) Director Ollin B Sykes acquired a total of 125,000 shares at an average price of $0.37. The insider spent around $46,737 to buy those shares.
- What's Happening: Charles & Colvard posted a quarterly loss of 9 cents per share.
- What Charles & Colvard Does: Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market.
- 交易：Charles & Colvard, Ltd.（納斯達克股票代碼：CTHR）董事奧林·賽克斯 共收購了12.5萬股股票 平均價格爲0.37美元。知情人士花費了約46,737美元購買了這些股票。
- 發生了什麼：查爾斯和科爾瓦德公佈的季度每股虧損爲9美分。
- Charles & Colvard 做什麼：Charles & Colvard Ltd 在珠寶市場製造、銷售和分銷成品珠寶，其中還包括莫桑石寶石。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。